Golden State Equity Partners’s Vaxart VXRT Stock Holding History

Golden State Equity Partners’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,000	Closed	-$1.21K	–	1729
2026 Q1	$1.21K	Buy	+2,000	New	+$1.21K	﹤0.01%	1757

Other funds holding VXRT

HWA

Heritage Wealth Advisors Richmond, Virginia $2.91B AUM 24.25% 1-Year Est. Return

LCM

LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

AIC

Archer Investment Corporation Carmel, Indiana $522M AUM 26.29% 1-Year Est. Return

Golden State Equity Partners's VXRT Position: Q2 2026 in Review

Golden State Equity Partners sold out of Vaxart (VXRT) in Q2 2026, closing a stake of 2,000 shares — an estimated $1.21K sold.

Golden State Equity Partners first reported a position in VXRT in Q1 2026 and held it in 1 quarter. The position peaked at $1.21K in Q1 2026. 4 funds tracked by Wall St. Rank hold VXRT as of Q2 2026.

Golden State Equity Partners reported no remaining Vaxart position as of Q2 2026 after selling out during the quarter.
Golden State Equity Partners sold 2,000 Vaxart shares in Q2 2026, an estimated $1.21K.
Golden State Equity Partners first reported a position in Vaxart in Q1 2026 and held it in 1 quarter.
Golden State Equity Partners's Vaxart position peaked at $1.21K in Q1 2026.
4 funds tracked by Wall St. Rank held Vaxart as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.